Literature DB >> 11317640

Recent progress in clinical and basic pertussis research.

U Heininger1.   

Abstract

UNLABELLED: Over the last decade, substantial progress has been made in the field of pertussis research. This includes better understanding of virulence mechanisms and their influence on the pathogenicity of Bordetella pertussis, increased awareness of the broad spectrum of disease and more insight into the host's immune response to infection, improved diagnostic tools, development, evaluation, introduction and implementation of several acellular pertussis vaccines and better understanding of the epidemiology of pertussis in adolescents and adults.
CONCLUSION: The major achievements in the field of pertussis research are reviewed and discussed. They have great impact on the current and future practice of paediatric, adolescent and adult medicine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11317640     DOI: 10.1007/pl00008429

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  Resurgence of Bordetella pertussis infection.

Authors:  Erica Weir
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

2.  A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.

Authors:  P M Luz; C T Codeço; G L Werneck; C J Struchiner
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

3.  Hemolytic uremic syndrome in an infant following Bordetella pertussis infection.

Authors:  I Pela; D Seracini; A Caprioli; F Castelletti; A Giammanco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

4.  Hemolytic uremic syndrome caused by Bordetella pertussis infection.

Authors:  Swasti Chaturvedi; Christoph Licht; Valerie Langlois
Journal:  Pediatr Nephrol       Date:  2010-02-10       Impact factor: 3.714

5.  Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland.

Authors:  Bettina Ute Tillmann; Hanns-Christian Tillmann; Ulrich Heininger; Jürg Lütschg; Peter Weber
Journal:  Eur J Pediatr       Date:  2005-02-25       Impact factor: 3.183

6.  Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.

Authors:  Tomasz Niedziela; Iwona Letowska; Jolanta Lukasiewicz; Marta Kaszowska; Anna Czarnecka; Lennart Kenne; Czeslaw Lugowski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.